MX9709647A - Derivados de estirilbencimidazol como inhibidores de proliferacion de celulas de musculo liso. - Google Patents

Derivados de estirilbencimidazol como inhibidores de proliferacion de celulas de musculo liso.

Info

Publication number
MX9709647A
MX9709647A MX9709647A MX9709647A MX9709647A MX 9709647 A MX9709647 A MX 9709647A MX 9709647 A MX9709647 A MX 9709647A MX 9709647 A MX9709647 A MX 9709647A MX 9709647 A MX9709647 A MX 9709647A
Authority
MX
Mexico
Prior art keywords
inhibitors
cell proliferation
smooth muscle
muscle cell
benzimidazole derivatives
Prior art date
Application number
MX9709647A
Other languages
English (en)
Other versions
MXPA97009647A (es
Inventor
Sie-Yearl Chai
Hassan Mahmoud Elokdah
Theodore Sylvester Sulkowski
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX9709647A publication Critical patent/MX9709647A/es
Publication of MXPA97009647A publication Critical patent/MXPA97009647A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe en la presente compuestos de formula (I) o (II), en los que R es fenilo o fenilo sustituido; o R es furilo, piridilo o quinolinilo; R y R son hidrogeno, halogeno, alquilo, alcoxi, nitro, carboxilo, alcoxiarbonilo o ariloxicarbonilo; R es hidrogeno, alquilo; o una sal farmacéuticamente aceptable de los mismos, los cuales son utiles como inhidibores de proliferacion de células de musculo liso.
MXPA/A/1997/009647A 1995-06-06 1997-12-05 Derivados de estirilbencimidazol como inhibidoresde proliferacion de celulas de musculo liso MXPA97009647A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US468271 1995-06-06
US08/468,271 US6444694B1 (en) 1995-06-06 1995-06-06 Styryl benzimidazole derivatives

Publications (2)

Publication Number Publication Date
MX9709647A true MX9709647A (es) 1998-07-31
MXPA97009647A MXPA97009647A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
HUP9900914A2 (hu) 1999-07-28
BR9609153A (pt) 1999-05-04
DE69615023T2 (de) 2002-06-06
PT830345E (pt) 2002-01-30
AU5968496A (en) 1996-12-24
CA2223585A1 (en) 1996-12-12
DK0830345T3 (da) 2001-11-19
AR002749A1 (es) 1998-04-29
EP0830345A1 (en) 1998-03-25
DE69615023D1 (de) 2001-10-11
HUP9900679A3 (en) 2001-07-30
HUP9900679A2 (hu) 1999-09-28
EP0830345B1 (en) 2001-09-05
ZA964693B (en) 1997-12-05
WO1996039391A1 (en) 1996-12-12
KR19990022266A (ko) 1999-03-25
ES2162063T3 (es) 2001-12-16
AU711965B2 (en) 1999-10-28
IL118385A0 (en) 1996-09-12
CN1192206A (zh) 1998-09-02
ATE205196T1 (de) 2001-09-15
JPH11506753A (ja) 1999-06-15
NZ309499A (en) 2000-08-25
US6444694B1 (en) 2002-09-03

Similar Documents

Publication Publication Date Title
TW359670B (en) Process for producing quinazolin-4-one derivatives
EP1527049B8 (en) Fused heterocyclic compounds as peptidase inhibitors
MY114679A (en) Aroyl-piperidine derivatives
NO20013369L (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
MY158055A (en) Tetrahydroquinoline derivatives and a process for preparing the same.
NO20023097D0 (no) Heterocykliske forbindelser med sulfonamidgrupper
ATE361748T1 (de) 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2- pyrazoline als cyclooxygenase-2 inhibitoren
MX9801410A (es) Nuevas n-aminoalquilfluorencarboxamidas; una nueva clase de ligandos especificos del subtipo del receptor de la dopamina.
GB2303851A (en) Pharmaceutical diketopiperazine compounds
ATE466861T1 (de) Aminderivate
ATE15198T1 (de) Blutdrucksenkende 1-substituierte spiro(piperidin-oxobenzoxazine).
KR970703324A (ko) 신규한 피리미딘 유도체(novel pyrimidine derivative)
NZ332481A (en) 5-[2,4-diaminopyrimidinylmethyl]phenyl substituted propanone (or propenone) isoquinoline derivatives and medicaments
HUP9900914A2 (hu) Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok
MY117159A (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation.
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
MX9709465A (es) Derivados de bencimidazol 2-sustituidos como inhibidores de la proliferacion de celulas del musculo liso.
TW350838B (en) Quinoline derivatives
NO961404L (no) 4-indolylpiperazinyl-derivater
ATE269851T1 (de) Benzimidazole derivate
ES2055651A1 (es) Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
MX9709646A (es) Derivados de bencimidazol como inhibidores de proliferacion de celulas de musculo liso.
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
ES8603414A1 (es) Un procedimiento para preparar un derivado de 1, 4-dihidropiridina disustituido en posicion 2, 6
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija